Alzahrani Hayat
Food Science and Nutrition, King Saud University, Riyadh , SAU.
Cureus. 2024 Nov 9;16(11):e73350. doi: 10.7759/cureus.73350. eCollection 2024 Nov.
Vitamin B12 is significant for DNA synthesis, red blood cell formation, and nervous system function. Inadequate vitamin B12 levels may result in a higher risk of depression, necessitating the need for supplementation to improve mood and cognitive function. However, the use of vitamin B12 supplementation varies across studies. This review aims to evaluate the effect of vitamin B12 supplementation on cognitive memory function and depressive symptoms among participants who may have mild cognitive impairment (MCI). This review adhered to the Cochrane Handbook and PRISMA guidelines. A comprehensive search was conducted across PubMed, CENTRAL, Medline, and Ovid, with no constraints on geography or demographics, up to August 31, 2024. Only randomized controlled trials (RCTs) were included. Data on study characteristics, treatment details, and outcomes were extracted. The risk of bias was assessed using the revised Cochrane ROB2 tool. A meta-analysis of the effect of vitamin B12 on cognitive memory and depression was conducted using Jamovi software (The jamovi project (2024). jamovi (Version 2.5) [Computer Software]. Retrieved from https://www.jamovi.org). Statistical significance was set at p < 0.05. The results yielded 483 records that were screened based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Excluding duplicates and irrelevant studies, the meta-analysis finally included nine RCTs. For cognitive memory function, eight of the nine included studies were analyzed, showing an average standardized mean difference of -0.03 (95% confidence interval (CI): -0.07 to 0.01), indicating no significant effect of vitamin B12 supplementation (p = 0.1801) and no significant heterogeneity. Regarding depressive symptoms, three of the nine included studies were analyzed, yielding an average standardized mean difference of -0.01 (95% CI: -0.0773 to 0.0525), also showing no significant effect (p = 0.708). These results suggest that vitamin B12 complex supplementation has an insignificant effect on cognitive function and depressive symptoms in the general population. However, further research is needed to explore the conditions under which B12 is most effective, providing clearer guidelines for its use in clinical practice.
维生素B12对DNA合成、红细胞形成和神经系统功能至关重要。维生素B12水平不足可能导致患抑郁症的风险更高,因此需要补充以改善情绪和认知功能。然而,不同研究中维生素B12补充剂的使用情况各不相同。本综述旨在评估维生素B12补充剂对可能患有轻度认知障碍(MCI)的参与者的认知记忆功能和抑郁症状的影响。本综述遵循Cochrane手册和PRISMA指南。截至2024年8月31日,在PubMed、CENTRAL、Medline和Ovid上进行了全面搜索,不受地理或人口统计学限制。仅纳入随机对照试验(RCT)。提取了关于研究特征、治疗细节和结果的数据。使用修订后的Cochrane ROB2工具评估偏倚风险。使用Jamovi软件(The jamovi project (2024). jamovi (Version 2.5) [计算机软件]. 取自https://www.jamovi.org)对维生素B12对认知记忆和抑郁的影响进行了荟萃分析。设定统计学显著性为p < 0.05。结果产生了483条记录,根据系统评价和荟萃分析的首选报告项目(PRISMA)标准进行筛选。排除重复和不相关的研究后,荟萃分析最终纳入了9项RCT。对于认知记忆功能,对9项纳入研究中的8项进行了分析,显示平均标准化均值差为 -0.03(95%置信区间(CI):-0.07至0.01),表明补充维生素B12没有显著效果(p = 0.1801),且无显著异质性。关于抑郁症状,对9项纳入研究中的3项进行了分析,平均标准化均值差为 -0.01(95% CI:-0.0773至0.0525),也显示无显著效果(p = 0.708)。这些结果表明,补充复合维生素B12对一般人群的认知功能和抑郁症状影响不显著。然而,需要进一步研究以探索B12最有效的条件,为其在临床实践中的使用提供更明确的指导。